Long-term moxifloxacin in complicated tuberculosis patients with adverse reactions or resistance to first line drugs

This publication has 22 references indexed in Scilit:

• Action of Fluoroquinolones and Linezolid on Logarithmic- and Stationary-Phase Culture of Mycobacterium tuberculosis
  Chemotherapy, 2004
• Safety profile of oral and intravenous moxifloxacin: Cumulative data from clinical trials and postmarketing studies
  Clinical Therapeutics, 2004
• Programmes and principles in treatment of multidrug-resistant tuberculosis
  The Lancet, 2004
• A randomized controlled trial (volunteer study) of sitafloxacin, enoxacin, levofloxacin and sparfloxacin phototoxicity
  British Journal of Dermatology, 2003
• Comparative Roles of Levofloxacin and Ofloxacin in the Treatment of Multidrug-Resistant Tuberculosis
  Chest, 2003
• The global situation of MDR-TB
  Tuberculosis, 2003
• Studies of the Early Bactericidal Activity of New Drugs for Tuberculosis
  American Journal of Respiratory and Critical Care Medicine, 2002
• The Treatment of Multidrug-Resistant Tuberculosis in Turkey
  New England Journal of Medicine, 2001
• Sparfloxacin in the treatment of drug resistant tuberculosis or intolerance of first line therapy
  European Respiratory Journal, 2001
• Standard Short-Course Chemotherapy for Drug-Resistant Tuberculosis
  JAMA, 2000